Estimating Breast Cancer Screening Use, Costs Among Women in 40s With Private Insurance

JAMA Internal Medicine

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, MARCH 23, 2020

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2020.0262?guestAccessKey=960a34b5-c0a5-4f44-83f0-b3c18ffd9fef&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=032320

 

What The Study Did: Researchers used a large commercial claims database to estimate the percentage of U.S. women in their 40s with private insurance who were eligible and received screening mammography in 2017 and national costs for this screening.

Authors: Natalia Kunst, M.Sc., of the University of Oslo in Norway, is the corresponding author.

 

(doi:10.1001/jamainternmed.2020.0262)

Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the articles for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.